RudaCure a été sélectionnée pour le Ministère de Science and ICT's 2021 Bio iCORE Project and will receive support for the next three years.
The Bio iCORE project is a program that helps national bioventures expand overseas. Through incubation, management, and administrative support from the Bio iCORE project team, ainsi que specialized education, mentoring, and consulting provided by dedicated overseas organizations, the program assists in establishing overseas subsidiaries and ultimately vise à create overseas funds. In this selection round, 5 global startup teams were chosen from among 12 pre-startup teams that completed national training, with a total of KRW 700 million in support over three years to promote overseas grant applications.
During the project evaluation, l'entreprise was highly recognized for its strategy for overseas entrée sur le marché, the completed national accord de licence, high prior research leading to a predicted high success rate, excellent capabilities in the développement de nouveaux médicaments process, and a very specific plan for overseas expansion strategy.
RudaCure prévoit d'utiliser this support to build upon its national licence contrat with Hanlim Pharmaceutical and further accelerate its expansion mondiale.